SCHEMBL16215950

SCHEMBL16215950

Fc1c(F)c(F)c(N(c2ccccc2)c2ccccc2)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
CRHBP P24387 1/20 0.35
ATM Q13315 1/20 0.35
CRHR2 Q13324 1/20 0.35
TLR9 Q9NR96 1/20 0.35
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13826009 0.92 ALDH1A1 (0.44) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL20100709 0.90 ALDH1A1 (0.39) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL24254708 0.87 CYP2C19 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL24254807 0.85 ALDH1A1 (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL24254706 0.81 ALDH1A1 (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL15909749 0.80 CYP1A2 (0.37) ALDH1A1TDP1KDM4ECYP1A2CYP3A4
SCHEMBL13826136 0.78 MAPT (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL24254702 0.77 SYK (0.32) ALDH1A1CYP3A4
SCHEMBL27871421 0.77 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL24254694 0.77 ALDH1A1 (0.35) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2799422-B1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER UNIV NAGOYA NAT UNIV CORP (JP) 2018-02-14 EP disclosed
US-9206107-B2 Method for producing carboxylic acid and alcohol by hydrolysis of ester NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-12-08 US disclosed
US-9206107-B2 Method for producing carboxylic acid and alcohol by hydrolysis of ester NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2015-12-08 US disclosed
US-20140378692-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-12-25 US disclosed
US-20140378692-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-12-25 US disclosed
EP-2799422-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER National University Corporation Nagoya University (JP) 2014-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378692-A1 METHOD FOR PRODUCING CARBOXYLIC ACID AND ALCOHOL BY HYDROLYSIS OF ESTER ADH5, ADH1C, ADH1A ALDH1A1 485/4885TDP1 4241/4885L3MBTL1 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.